021-51111890
购物车（）
sales@molnova.cn
Oxonic Acid (potassium salt)
CAS No. 2207-75-2
Oxonic Acid (potassium salt) ( Potassium azaorotate;Potassium otastat;Potassium oxonate )
产品货号. M20562 CAS No. 2207-75-2
Oxonic Acid (potassium salt) is a uricase inhibitor that prevents metabolism and excretion of uric acid and induces embryotoxicity and nephrotoxicity in rats.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 500MG | ￥365 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Oxonic Acid (potassium salt)
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Oxonic Acid (potassium salt) is a uricase inhibitor that prevents metabolism and excretion of uric acid and induces embryotoxicity and nephrotoxicity in rats.
-
产品描述Oxonic Acid (potassium salt) is a uricase inhibitor that prevents metabolism and excretion of uric acid and induces embryotoxicity and nephrotoxicity in rats.
-
同义词Potassium azaorotate;Potassium otastat;Potassium oxonate
-
通路Others
-
靶点Other Targets
-
受体uricase
-
研究领域——
-
适应症——
化学信息
-
CAS Number2207-75-2
-
分子量195.17
-
分子式C4H2KN3O4
-
纯度>98% (HPLC)
-
溶解度H2O:9.09 mg/mL (46.57 mM; Need ultrasonic)
-
SMILES[K+].[O-]C(=O)c1nc(=O)[nH]c(=O)[nH]1
-
化学全称Potassium 1456-tetrahydro-46-dioxo-135-triazine-2-carboxylate
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Yoshisue K Masuda H Matsushima Eet al.Tissue distribution and biotransformation of potassium oxonate after oral administration of a novel antitumor agent (drug combination of tegafur 5-chloro-24-dihydroxypyridine and potassium oxonate) to rats[J].Drug Metab Dispos. 2000 Oct;28(10):1162-7.
产品手册
关联产品
-
TCV-309 chloride
A highly potent and selective platelet activating factor (PAF) antagonist; inhibits PAF-induced aggregation of rabbit and human platelets with IC50s of 33 nM and 55 nM respectively.
-
Pinostilbene
Pinostilbene obviously attenuates the phosphorylation of c-Jun and JNK triggered by 6-OHDA.
-
Ethyl linoleate
Ethyl linoleate is a natural product and can inhibit the expression of inflammatory mediators and the development of atherosclerotic lesions.
